drugset / Trial / NCT06008197
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
Phase 3
Recruiting
5200 enrolled
Colorado Prevention Center
Bayer · collabSt. Luke's Hospital, Kansas City, Missouri · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Finerenone will be compared to placebo to determine efficacy and safety of treatment in patients hospitalized with acute decompensated heart failure (HF) and mildly reduced or preserved left ventricular ejection fraction.
Timeline
- Start
- 2024-01-17
- Primary completion
- 2027-11
- Completion
- 2027-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Finerenone | Small molecule | — | Oral |